EdgarLookup

Alpha Investment Inc. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Alpha Investment Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
-1516.3%
Profit Margin
Net income ÷ revenue
-3664128.6%
Return on Assets
Net income ÷ assets
-1.01x
Debt-to-Equity
Total liabilities ÷ equity
+102.7%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2021 $33.8K Jun 20, 2023
FY2021 Dec 31, 2020 $16.7K Aug 8, 2022
FY2020 Dec 31, 2019 $90.1K Oct 13, 2021
FY2019 Dec 31, 2018 $46.8K Mar 18, 2020
FY2018 Dec 31, 2017 $48.6K Apr 15, 2019
FY2017 Dec 31, 2016 $0 Jun 20, 2018

Gross Profit

Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $19.6K Jun 20, 2018
FY2017 Dec 31, 2016 $0 Jun 20, 2018

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 ($513.0K) Apr 17, 2024
FY2023 Dec 31, 2022 ($3.10M) Apr 17, 2024
FY2022 Dec 31, 2021 ($2.06M) Jun 20, 2023
FY2021 Dec 31, 2020 ($1.07M) Aug 8, 2022
FY2020 Dec 31, 2019 ($1.70M) Oct 13, 2021
FY2019 Dec 31, 2018 ($1.61M) Mar 18, 2020
FY2018 Dec 31, 2017 ($584.9K) Apr 15, 2019
FY2017 Dec 31, 2016 ($19.3K) Jun 20, 2018
FY2016 Dec 31, 2015 ($23.2K) Mar 16, 2017
FY2015 Dec 31, 2014 ($14.7K) Mar 18, 2016

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 ($327.9K) Apr 17, 2024
FY2023 Dec 31, 2022 ($551.2K) Apr 17, 2024
FY2022 Dec 31, 2021 ($2.06M) Jun 20, 2023
FY2021 Dec 31, 2020 ($1.06M) Aug 8, 2022
FY2020 Dec 31, 2019 ($1.39M) Oct 13, 2021
FY2019 Dec 31, 2018 ($503.4K) Mar 18, 2020
FY2018 Dec 31, 2017 ($344.5K) Apr 15, 2019
FY2017 Dec 31, 2016 ($17.6K) Jun 20, 2018
FY2016 Dec 31, 2015 ($22.0K) Mar 16, 2017
FY2015 Dec 31, 2014 ($14.3K) Mar 18, 2016

R&D Expense

Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.

Fiscal Year Period End Value Filed
FY2015 Dec 31, 2015 $1.0K Mar 18, 2016

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 ($32.5K) Apr 17, 2024
FY2023 Dec 31, 2022 ($109.2K) Apr 17, 2024
FY2022 Dec 31, 2021 ($399.5K) Jun 20, 2023
FY2021 Dec 31, 2020 ($547.2K) Aug 8, 2022
FY2020 Dec 31, 2019 ($2.04M) Oct 13, 2021
FY2019 Dec 31, 2018 ($369.0K) Mar 18, 2020
FY2018 Dec 31, 2017 ($289.7K) Apr 15, 2019
FY2017 Dec 31, 2016 ($17.5K) Jun 20, 2018

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2017 $1.9K Apr 15, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $14 Apr 17, 2024
FY2023 Dec 31, 2022 $0 Apr 17, 2024
FY2022 Dec 31, 2021 $904 Jun 20, 2023
FY2021 Dec 31, 2020 $1.35M Aug 8, 2022
FY2020 Dec 31, 2019 $4.03M Oct 13, 2021
FY2019 Dec 31, 2018 $3.63M Mar 18, 2020
FY2018 Dec 31, 2017 $3.47M Apr 15, 2019
FY2017 Dec 31, 2016 $382 Jun 20, 2018
FY2016 Dec 31, 2015 $421 Mar 16, 2017
FY2015 Dec 31, 2014 $4.4K Mar 18, 2016

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 $4.90M Apr 17, 2024
FY2023 Dec 31, 2022 $4.30M Apr 17, 2024
FY2022 Dec 31, 2021 $1.16M Jun 20, 2023
FY2021 Dec 31, 2020 $712.4K Aug 8, 2022
FY2020 Dec 31, 2019 $137.3K Oct 13, 2021
FY2019 Dec 31, 2018 $70.9K Mar 18, 2020
FY2018 Dec 31, 2017 $51.7K Apr 15, 2019
FY2017 Dec 31, 2016 $58.4K Jun 20, 2018
FY2016 Dec 31, 2015 $39.1K Mar 16, 2017
FY2015 Dec 31, 2014 $19.9K Mar 18, 2016

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 ($4.87M) Apr 17, 2024
FY2023 Dec 31, 2022 ($4.37M) Apr 17, 2024
FY2022 Dec 31, 2021 ($1.32M) Jun 20, 2023
FY2021 Dec 31, 2020 $418.6K Aug 8, 2022
FY2020 Dec 31, 2019 $1.11M Oct 13, 2021
FY2019 Dec 31, 2018 $720.4K Mar 18, 2020
FY2018 Dec 31, 2017 $1.83M Apr 15, 2019
FY2018 Dec 31, 2016 ($58.0K) Apr 15, 2019
FY2017 Dec 31, 2015 ($38.7K) Jun 20, 2018
FY2016 Dec 31, 2014 ($15.5K) Mar 16, 2017

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 ($10.94M) Apr 17, 2024
FY2023 Dec 31, 2022 ($10.40M) Apr 17, 2024
FY2022 Dec 31, 2021 ($7.27M) Jun 20, 2023
FY2021 Dec 31, 2020 ($5.15M) Aug 8, 2022
FY2020 Dec 31, 2019 ($4.02M) Oct 13, 2021
FY2019 Dec 31, 2018 ($2.28M) Mar 18, 2020
FY2018 Dec 31, 2017 ($649.4K) Apr 15, 2019
FY2017 Dec 31, 2016 ($62.5K) Jun 20, 2018
FY2016 Dec 31, 2015 ($43.2K) Mar 16, 2017
FY2015 Dec 31, 2014 ($20.0K) Mar 18, 2016

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $2.54M Jun 20, 2018
FY2017 Dec 31, 2016 $382 Jun 20, 2018
FY2017 Dec 31, 2015 $416 Jun 20, 2018
FY2016 Dec 31, 2014 $4.3K Mar 16, 2017
FY2015 Dec 31, 2013 $665 Mar 18, 2016

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 0 Apr 17, 2024
FY2023 Dec 31, 2022 0 Apr 17, 2024
FY2022 Dec 31, 2021 0 Jun 20, 2023
FY2021 Dec 31, 2020 0 Aug 8, 2022
FY2016 Dec 31, 2016 0 Mar 16, 2017
FY2016 Dec 31, 2015 0 Mar 16, 2017
FY2015 Dec 31, 2014 0 Mar 18, 2016

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2023 Dec 31, 2023 11.22M Apr 17, 2024
FY2023 Dec 31, 2022 9.72M Apr 17, 2024
FY2022 Dec 31, 2021 9.72M Jun 20, 2023
FY2021 Dec 31, 2020 40.29M Aug 8, 2022
FY2020 Dec 31, 2019 40.29M Oct 13, 2021
FY2019 Dec 31, 2018 40.24M Mar 18, 2020
FY2018 Dec 31, 2017 40.24M Apr 15, 2019
FY2017 Dec 31, 2016 36.55M Jun 20, 2018
FY2016 Dec 31, 2015 36.55M Mar 16, 2017
FY2015 Dec 31, 2014 11.55M Mar 18, 2016